Herein, we report a patient with human epidermal growth factor receptor 2 (HER2)-positive recurrent breast cancer with accompanying PTTM without pulmonary hypertension; the diagnosis was made antemortem, and the patient responded well to trastuzumab therapy. Here, ERBB2 is linked to pulmonary arterial hypertension.